Nang Kuang Pharmaceutical Co Ltd (1752.TW) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Taiwan · ISIN TW0001752004

Price
30.05 TWD
Market cap
3.03 bn TWD
P/E (2025)
12.42
P/S (2025)
1.40
Dividend yield
5.32 %
Net margin
11.28 %
Return on equity (ROE)
9.82 %
Return on assets (ROA)
6.38 %

Nang Kuang Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue2.20 bn TWD2.16 bn TWD
Gross profit747.79 m TWD768.86 m TWD
Operating income307.55 m TWD295.67 m TWD
EBIT308.73 m TWD295.79 m TWD
Net income243.41 m TWD243.95 m TWD
Diluted EPS – continuing operations2.40 TWD2.42 TWD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Nang Kuang Pharmaceutical Co Ltd

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in alimentary and metabolism, blood, antineoplastic and immunomodulatory, dermatological, genito-urinary and sex hormone, systemic hormone and antibacterial, cosmetics, and hospital solutions. In addition, the company is involved in trading of pharmaceuticals. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.